1. Introduction {#sec1}
===============

α-Hydroxy-β-keto ester and amide moieties are the main structural units of certain natural products and pharmaceutical compounds, serving as important contributors to various biological activities.^[@ref1]−[@ref4]^ These functional units, also serving as key intermediates, appear in many multistep reaction sequences, such as the *Aspidosperma* alkaloids 11-demethoxyvindoline and vindoline, Passerini adducts, and 3-substituted oxindoles.^[@ref5]−[@ref9]^ To date, a number of methods with a variety of electrophilic oxidants, including oxaziridines,^[@ref10]−[@ref13]^ oxygen,^[@ref1],[@ref14]−[@ref17]^ DDQ,^[@ref18]^ dimethyldioxirane,^[@ref19]^ nitroso compounds,^[@ref20]^*m*-CPBA,^[@ref8]^ and Mn(OAc)~3~,^[@ref21]^ have been developed to prepare α-hydroxy-β-dicarbonyl moieties,^[@ref22]−[@ref25]^ and the hydroxylation of β-dicarbonyl enolates is the most direct approach to this structural unit. However, despite considerable efforts in the area of synthesis methods toward α-hydroxycarbonyl derivatives, the development of practical, diverse synthesis procedures to access α-hydroxy-β-ketoamides starting from β-ketoamides in the presence of novel oxygen sources is highly desirable.

Organoiodine reagents, possessing reactivity similar to that of transition metals,^[@ref26]^ are widely used in various organic reactions as selective oxidants and environmentally friendly reagents, including aminations, oxidations, halogenations, C--C bond-forming reactions, rearrangements, and transition-metal-catalyzed reactions.^[@ref27]−[@ref49]^ They are also used for the acetalization of carbonyl compounds.^[@ref26],[@ref50]^ In 2005, in a perspective of Moriarty group's work in hypervalent iodine chemistry, it was reported that the alcoholysis of iodobenzene diacetate (PIDA: PhI(OAc)~2~) in MeOH can generate the active reagent (dimethoxyiodo)benzene (PhI(OMe)~2~).^[@ref26]^ The concomitantly formed enolate anion **1′** subsequently adds to the PhI(OMe)~2~ to yield intermediate **A**, which results in intermediate **B** via the addition of a methoxide anion. Then, the oxirane **C** is formed, accompanying the release of one molecule of PhI from the intramolecular **B** nucleophilic displacement via the alkoxide anion. The reaction is completed with the attack of a second methoxide ion on oxirane **C** to yield product **2** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). The procedure has been shown to work well for a large range of structural types.^[@ref26],[@ref51]−[@ref55]^ However, a literature review disclosed that no systematic work has focused on this type of reaction starting from β-ketoamides to date.^[@ref55]−[@ref57]^ Herein, we present our recent progress on a hypervalent-organoiodine-promoted controllable tandem oxidative intramolecular α-hydroxylation/β-acetalization reaction of β-ketoamides as well as the application of this chemistry to the construction of α-hydroxy-β-ketoamides and quinolinone derivatives.

![Schematic of the α-Hydroxydimethylacetal Formation Reaction of Enolizable Ketone](ao-2017-01526e_0002){#sch1}

We recently developed a facile and direct oxidative reaction for the synthesis of vicinal tricarbonyl amides (VTAs) in moderate to good yields (53--88%) starting from various readily available β-ketoamides (**1**) in the presence of phenyliodine(III) bis(trifluoroacetate) (PIFA) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref58]^ While optimizing reaction conditions, a small amount of byproduct was isolated under alkaline conditions in MeOH solvent and characterized as 2-hydroxy-3,3-dimethoxy-*N*-phenylbutanamide (**2a**) based on its NMR spectral and analytical data. This delightful preliminary result prompted us to attempt to develop a controllable tandem oxidative α-hydroxylation/β-acetalization reaction of β-ketoamides in the preparation of functionalized amides **2** because this type of product is useful in the synthesis of 2-indolinones and quinolines.^[@ref5],[@ref56],[@ref59]^

![Our recent work on the synthesis of VTAs.](ao-2017-01526e_0001){#fig1}

2. Results and Discussion {#sec2}
=========================

In light of these findings, commercially available β-ketoamide (**1a**) was selected as a model substrate to explore the optimal conditions for this tandem reaction. Some of the key experiments are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. We found that the highest yield of the desired compound **2a** was 78% when compound **1a** (0.2 mmol) was treated with phenyliodonium diacetate (PIDA) (1.2 equiv) and NaOH (50% aq, 0.2 mL) in MeOH at 25 °C after 1 h ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). However, increasing or decreasing the amount of PIDA both led to a slightly lower yield of **2a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 2 and 3). Other trivalent iodine reagents, including PIFA and PhIO, could also promote the reaction but gave a lower yield than PIDA ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 4 and 5). Further investigation using pentavalent iodine reagents, such as IBX and DMP, confirmed that they were entirely inefficient for the conversion ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 6 and 7); similar reports have disclosed a different oxidation capacity with trivalent iodine and pentavalent iodine reagents.^[@ref28],[@ref49]^ Different percentages of NaOH were also tested for the reaction, and they all gave yields lower than that of entry 1 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 8--10). The experiments also showed that it is of no use to further increase the yield of **2a** by decreasing or increasing the reaction temperature ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 11 and 12). Other bases, such as KOH and K~2~CO~3~, only afforded the desired product **2a** in 69 and 55% yields, respectively ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 13 and 14).

###### Survey of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-01526e_0005){#GRAPHIC-d7e504-autogenerated}

  entry   oxidant (equiv)   base (percent, volume/mL)   *T*/°C   yield of **2a**/%
  ------- ----------------- --------------------------- -------- -------------------
  1       PIDA (1.5)        NaOH (50%, 0.2)             25       78
  2       PIDA (1.0)        NaOH (50%, 0.2)             25       65
  3       PIDA (2.0)        NaOH (50%, 0.2)             25       61
  4       PIFA (1.5)        NaOH (50%, 0.2)             25       70
  5       PhIO (1.5)        NaOH (50%, 0.2)             25       74
  6       IBX (1.5)         NaOH (50%, 0.2)             25       0
  7       DMP (1.5)         NaOH (50%, 0.2)             25       0
  8       PIDA (1.5)        NaOH (50%, 0.5)             25       63
  9       PIDA (1.5)        NaOH (30%, 0.2)             25       73
  10      PIDA (1.5)        NaOH (60%, 0.2)             25       64
  11      PIDA (1.5)        NaOH (50%, 0.2)             0        76
  12      PIDA (1.5)        NaOH (50%, 0.2)             50       65
  13      PIDA (1.5)        KOH (50%, 0.2)              25       69
  14      PIDA (1.5)        K~2~CO~3~ (50%, 0.2)        25       55

Reaction conditions: **1a** (0.2 mmol), oxidant (1.5 equiv), and base in MeOH (1.5 mL) in 1 h at 25 °C temperature.

With the optimized conditions in hand ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1), we proceeded to investigate the scope of this tandem oxidative α-hydroxylation/β-acetalization reaction. The variation of amide moieties (substituents of the R^1^ and R^2^) was investigated first. As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, a phenyl group (**1a**) and various other aryl groups bearing electron-donating groups (e.g., **1b--j**: −OMe and −Me) and electron-withdrawing groups (e.g., **1k--o**: −Cl and −NO~2~) at the ortho, meta, or para position of the phenyl ring converted to the corresponding α-hydroxylated and β-acetalized amides **2a--o** in 57--81% yields. Furthermore, *N*,*N*′-(1,4-phenylene)bis(acetoacetamide) **1p** also gave the target compound **2p** in 20% yield via the formation of six new C--O bonds simultaneously in one pot. *N*-Benzyl-substituted starting materials **1q** and **1r** and other *N*-alkyl-substituted aliphatic secondary and tertiary amides **1s** and **1t** also afforded the desired products **2q--t** in 54--74% yields. However, the primary amide **1u** was poorly tolerated by this tandem reaction, and some of the decomposition products were detected by LC--MS. This observation prompted us to explore a wider range of starting material **1**. Compounds **1v** and **1w** were then selected and tested as starting materials. The results revealed that the reaction failed to afford the desired products **2v** and **2w** but resulted in an unidentified complex mixture. This limitation suggested that the amide moiety is important to the conversion.

###### Extension of the Reaction Scope[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao-2017-01526e_0006){#gr5}

Unless otherwise indicated, all reactions were carried out with **1** (0.2 mmol) and PIDA (1.5 equiv) in alcohol (1.5 mL) at 25 °C.

Isolated yield.

95% of **1w** was recovered.

15% of **1x** was recovered.

21% of **1y** was recovered, and the yield of **2y** was not increased by prolonging the reaction time.

The investigation of the R^3^ group disclosed that it could affect the reaction significantly. Compound **1x** (R^3^ = Ph) afforded product **2x** in only 30% yield, along with the recovered **1x** (15%) and some unidentified complex mixtures; moreover, the yield of **2x** could not be further improved by increasing the amount of PIDA (3.0 equiv) or the reaction temperature. This might be caused by the large steric hindrance of the phenyl group. Hence, Et-substituted starting material **1y** was employed in the reaction. As a result, we obtained a slightly higher yield of **2y** (50%) than that of **2x** (30%). Furthermore, compared with the reactions using Me-, Et-, ^i^Pr-, and ^*t*^Bu-substituted starting materials (**1a** and **1y--a′**), it was found that the yields of **2a** and **2y--a′** were gradually reduced (from 77 to 50 to 20 to 0%) with increasing steric hindrance. In an attempt to investigate a wider scope of alcohol-substituted starting materials, ethylene glycol and 1-pentanol were also tested with the reaction. They performed poorly in the reaction; only ethylene glycol led to the desired product **2b′** in 20% yield in addition to a complex mixture, and compound **2c′** was not detected by thin-layer chromatography (TLC). To our delight, α-methyl-substituted starting material **1d′** still afforded the desired product **2d′** in 41% yield.

The previous studies clearly demonstrated that α-hydroxy amide derivatives are important building blocks for the construction of 2-indolinones and quinolines.^[@ref5],[@ref56],[@ref59]^ According to these reports, we randomly selected several 2-hydroxy-3,3-dimethoxy-*N*-arylbutanamides (**2**) for further derivatization using the method detailed herein. It was found that compounds **2a**, **2f**, **2i**, and **2l** cyclized smoothly to the quinoline derivatives **3a**, **3f**, **3i**, and **3l** in yields of 66, 75, 84, and 74%, respectively ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). It is noteworthy that the dimethyl acetal protecting group at the 3 position was removed simultaneously during the cyclization process.^[@ref60]^ This result prompted us to attempt to obtain controlled deprotected products **4** from **2**. Still in the presence of sulfuric acid, the reaction could produce the deprotecting products **4j**, **4l**, **4o**, **4s**, and **4t** in 48--88% yields when we only reduce the reaction temperature from 80 to 25 °C ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). All of these applications demonstrated the usefulness of compound **2**, although they are very elementary.

![Application of **2** for the Synthesis of Quinoline Derivatives **3**](ao-2017-01526e_0003){#sch2}

![Deprotection of **2** to Deprotected Products **4**](ao-2017-01526e_0004){#sch3}

3. Conclusions {#sec3}
==============

A systemically oxidative intramolecular α-hydroxylation/β-acetalization tandem reaction of β-ketoamides was described for the synthesis of 2-hydroxy-3,3-dimethoxy-*N*-substituted butanamides in the presence of PIDA and NaOH. Notably, this metal-free reaction is advantageous owing to its readily available starting materials, simple operation, moderate to good yields, and dense and flexible substitution patterns. Further applications of this chemistry to the construction of α-hydroxy-β-ketoamides and quinolinone derivatives have been developed simultaneously so that the method, at present, can be considered as an alternative procedure for producing these types of functionalized small molecules.

4. Experimental Section {#sec4}
=======================

4.1. General Remarks {#sec4-1}
--------------------

All reactions were carried out under air atmosphere, unless otherwise indicated. Other all reagents were purchased from commercial sources and used without further treatment, unless otherwise indicated. Petroleum ether (PE) used refers to the 60--90 °C boiling point fraction of petroleum. Ethyl acetate is abbreviated as EA. ^1^H NMR and ^13^C{^1^H} NMR spectra were recorded on a Bruker AVANCE/600 (^1^H: 600 MHz and ^13^C{^1^H}: 150 MHz at 25 °C) or a Bruker AVANCE/400 (^1^H: 400 MHz and ^13^C{^1^H}: 100 MHz at 25 °C) using tetramethylsilane as internal standard. Data are represented as follows: chemical shift, integration, multiplicity (br = broad, s = singlet, d = doublet, dd = double doublet, t = triplet, q = quartet, and m = multiplet), and coupling constants in hertz (Hz). All high-resolution mass spectra (HRMS) were measured on a mass spectrometer by using electrospray ionization (ESI-oa-TOF), and the purity of all samples used for HRMS (\>95%) was confirmed by ^1^H NMR and ^13^C{^1^H} NMR spectroscopic analyses. Melting points were measured on a melting point apparatus equipped with a thermometer and were uncorrected. All reactions were monitored by TLC with GF254 silica gel-coated plates. Flash chromatography was carried out on SiO~2~ (silica gel 200--300 mesh).

4.2. Typical Experimental Procedure for **2** (**2a** as an Example) {#sec4-2}
--------------------------------------------------------------------

To a round-bottom flask (25 mL) were added 3-oxo-*N*-phenylbutanamide **1a** (35 mg, 0.2 mmol), (diacetoxyiodo)benzene (96.6 mg, 0.3 mmol), and NaOH (0.2 mL, 50% aq), and the mixture was well-stirred for 1 h in MeOH (1.5 mL) at 25 °C (the whole process was closely monitored by TLC). After the completion of the reaction, the residue was purified by a short flash silica gel column chromatography (eluent: EA/PE = 1/20) to give 2-hydroxy-3,3-dimethoxy-*N*-phenylbutanamide **2a** as a white solid (37 mg, 77%).

### 4.2.1. 2-Hydroxy-3,3-dimethoxy-*N*-phenylbutanamide (**2a**) {#sec4-2-1}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (37 mg, 77%); mp: 104--106 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.57 (s, 1H), 7.51 (d, *J* = 7.8 Hz, 2H), 7.35 (t, *J* = 7.5 Hz, 2H), 7.15 (t, *J* = 7.2 Hz, 1H), 4.27 (d, 1H), 4.08 (d, *J* = 3.6 Hz, 1H), 3.39 (d, *J* = 10.8 Hz, 6H), 1.28 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.3, 137.1, 129.2, 124.7, 119.7, 101.9, 77.2, 77.0, 76.8, 71.0, 48.8, 48.7, 17.0. HRMS (ESI), *m*/*z* calcd for C~12~H~17~NNaO~4~ (\[M + Na\]^+^), 262.1050; found, 262.1045.

### 4.2.2. 2-Hydroxy-3,3-dimethoxy-*N*-(4-methoxyphenyl)butanamide (**2b**) {#sec4-2-2}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a brown solid (35 mg, 65%); mp: 94--96 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.44 (s, 1H), 7.42 (d, *J* = 9.0 Hz, 2H), 6.88 (d, *J* = 9.0 Hz, 2H), 4.26 (d, 1H), 4.10 (d, *J* = 3.6 Hz, 1H), 3.80 (s, 3H), 3.38 (d, *J* = 8.4 Hz, 6H), 1.28 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.2, 156.7, 130.3, 121.5, 114.3, 101.9, 70.9, 55.5, 48.8, 48.7, 17.0. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~5~ (\[M + Na\]^+^), 292.1155; found, 292.1155.

### 4.2.3. 2-Hydroxy-3,3-dimethoxy-*N*-(3-methoxyphenyl)butanamide (**2c**) {#sec4-2-3}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (38 mg, 71%); ^1^H NMR (600 MHz, CDCl~3~): δ 8.57 (s, 1H), 7.28 (t, 1H), 7.24 (t, *J* = 8.1 Hz, 1H), 6.97 (dd, *J* = 8.0, 1.0 Hz, 1H), 6.70 (dd, *J* = 8.1, 1H), 4.26 (d, 1H), 4.07 (d, *J* = 3.6 Hz, 1H), 3.82 (s, 3H), 3.39 (d, *J* = 10.8 Hz, 6H), 1.28 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.5, 160.3, 138.4, 129.9, 111.9, 110.4, 105.6, 101.9, 71.1, 55.4, 48.8, 48.7, 17.0. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~5~ (\[M + Na\]^+^), 292.1155; found, 292.1162.

### 4.2.4. 2-Hydroxy-3,3-dimethoxy-*N*-(2-methoxyphenyl)butanamide (**2d**) {#sec4-2-4}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (43 mg, 80%); mp: 110--112 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 9.38 (s, 1H), 8.30 (d, *J* = 8.4 Hz, 1H), 7.08 (t, *J* = 7.8 Hz, 1H), 6.98 (t, *J* = 7.5 Hz, 1H), 6.90 (d, *J* = 8.4 Hz, 1H), 4.30 (d, *J* = 3.6 Hz, 1H), 4.16 (d, 1H), 3.91 (s, 3H), 3.40 (d, *J* = 8.4 Hz, 6H), 1.26 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.4, 148.4, 127.1, 124.2, 121.2, 120.0, 110.1, 101.8, 71.1, 55.8, 48.8, 48.7, 16.8. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~5~ (\[M + Na\]^+^), 292.1155; found, 292.1155.

### 4.2.5. *N*-(2,5-Dimethoxyphenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2e**) {#sec4-2-5}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a light yellow solid (36 mg, 60%); mp: 77--79 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 9.41 (s, 1H), 8.03 (d, 1H), 6.82 (d, *J* = 9.0 Hz, 1H), 6.61 (dd, *J* = 9.0, 1H), 4.30 (d, 1H), 4.13 (d, *J* = 3.6 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.39 (d, *J* = 7.8 Hz, 6H), 1.27 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.4, 154.0, 142.6, 127.8, 111.0, 109.0, 106.2, 101.8, 71.1, 56.4, 55.8, 48.8, 48.7, 16.9. HRMS (ESI), *m*/*z* calcd for C~14~H~21~NNaO~6~ (\[M + Na\]^+^), 322.1261; found, 322.1261.

### 4.2.6. 2-Hydroxy-3,3-dimethoxy-*N*-(*p*-tolyl)butanamide (**2f**) {#sec4-2-6}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (41 mg, 81%); mp: 89--91 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.50 (s, 1H), 7.39 (d, *J* = 8.4 Hz, 2H), 7.15 (d, *J* = 8.4 Hz, 2H), 4.26 (d, *J* = 3.6 Hz, 1H), 4.10 (d, *J* = 3.6 Hz, 1H), 3.38 (d, *J* = 8.4 Hz, 6H), 2.33 (s, 3H), 1.27 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 169.3, 134.6, 134.4, 129.6, 119.8, 101.9, 71.0, 48.8, 48.6, 20.9, 17.0. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1206.

### 4.2.7. 2-Hydroxy-3,3-dimethoxy-*N*-(*m*-tolyl)butanamide (**2g**) {#sec4-2-7}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow solid (29 mg, 57%); mp: 78--80 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.52 (s, 1H), 7.36 (s, 1H), 7.30 (d, *J* = 8.0 Hz, 1H), 7.23 (t, *J* = 7.8 Hz, 1H), 6.96 (d, *J* = 7.6 Hz, 1H), 4.26 (d, *J* = 2.8 Hz, 1H), 4.09 (d, *J* = 3.2 Hz, 1H), 3.39 (d, *J* = 7.6 Hz, 6H), 2.36 (s, 3H), 1.28 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 169.4, 139.2, 137.1, 129.0, 125.5, 120.4, 116.9, 101.9, 71.1, 48.8, 48.7, 21.5, 17.0. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1203.

### 4.2.8. 2-Hydroxy-3,3-dimethoxy-*N*-(*o*-tolyl)butanamide (**2h**) {#sec4-2-8}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (35 mg, 70%); ^1^H NMR (400 MHz, CDCl~3~): δ 8.64 (s, 1H), 8.02 (d, *J* = 8.0 Hz, 1H), 7.21 (dd, *J* = 13.8, 7.8 Hz, 2H), 7.08 (t, *J* = 7.4 Hz, 1H), 4.32 (d, *J* = 3.2 Hz, 1H), 4.16 (d, *J* = 3.6 Hz, 1H), 3.40 (d, *J* = 4.4 Hz, 6H), 2.27 (s, 3H), 1.31 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 169.4, 135.5, 130.5, 127.4, 127.0, 124.9, 121.5, 101.9, 71.1, 48.9, 48.8, 17.7, 16.9. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1201.

### 4.2.9. *N*-(2,4-Dimethylphenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2i**) {#sec4-2-9}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (36 mg, 67%); mp: 79--81 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.54 (s, 1H), 7.84 (d, *J* = 7.8 Hz, 1H), 7.03 (t, 2H), 4.31 (d, *J* = 3.6 Hz, 1H), 4.17 (d, *J* = 3.6 Hz, 1H), 3.40 (d, *J* = 4.2 Hz, 6H), 2.30 (s, 3H), 2.23 (s, 3H), 1.30 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.3, 134.7, 132.9, 131.2, 127.6, 127.5, 121.7, 101.9, 70.9, 48.8, 48.8, 20.8, 17.6, 16.9. HRMS (ESI), *m*/*z* calcd for C~14~H~21~NNaO~4~ (\[M + Na\]^+^), 290.1363; found, 290.1365.

### 4.2.10. 2-Hydroxy-*N*-mesityl-3,3-dimethoxybutanamide (**2j**) {#sec4-2-10}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (37 mg, 65%); mp: 103--105 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 7.99 (s, 1H), 6.90 (s, 2H), 4.36 (s, 1H), 4.15 (s, 1H), 3.40 (s, 6H), 2.27 (s, 3H), 2.18 (s, 6H), 1.38 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.7, 137.1, 134.6, 130.7, 129.1, 101.9, 70.7, 48.8, 48.7, 20.9, 18.6, 17.0. HRMS (ESI), *m*/*z* calcd for C~15~H~23~NNaO~4~ (\[M + Na\]^+^), 304.1519; found, 304.1520.

### 4.2.11. *N*-(5-Chloro-2-methoxyphenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2k**) {#sec4-2-11}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (36 mg, 65%); mp: 60--62 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 9.40 (s, 1H), 8.37 (d, 1H), 7.03 (dd, *J* = 8.4, 1H), 6.80 (d, *J* = 9.0 Hz, 1H), 4.29 (d, 1H), 4.06 (d, 1H), 3.89 (s, 3H), 3.39 (d, *J* = 9.0 Hz, 6H), 1.26 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.6, 146.9, 127.9, 126.2, 123.6, 119.9, 110.9, 101.8, 71.2, 56.1, 48.8, 48.7, 16.9. HRMS (ESI), *m*/*z* calcd for C~12~H~18~ClNaNO~5~ (\[M + Na\]^+^), 326.0766; found, 326.0770.

### 4.2.12. *N*-(4-Chlorophenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2l**) {#sec4-2-12}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a light yellow solid (44 mg, 80%); mp: 106--108 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.60 (s, 1H), 7.46 (d, *J* = 8.4 Hz, 2H), 7.29 (d, *J* = 8.4 Hz, 2H), 4.26 (d, 1H), 4.03 (d, *J* = 3.6 Hz, 1H), 3.37 (d, *J* = 15.6 Hz, 6H), 1.26 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.5, 135.7, 129.7, 129.2, 121.0, 120.9, 101.8, 71.1, 48.9, 48.8, 17.0. HRMS (ESI), *m*/*z* calcd for C~12~H~16~ClNNaO~4~ (\[M + Na\]^+^), 296.0660; found, 296.0663.

### 4.2.13. *N*-(3-Chlorophenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2m**) {#sec4-2-13}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (36 mg, 65%); mp: 110--112 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.62 (s, 1H), 7.62 (t, 1H), 7.38 (dd, *J* = 7.8, 1H), 7.29--7.26 (m, 1H), 7.12 (dd, *J* = 7.8, 1H), 4.27 (d, *J* = 3.6 Hz, 1H), 3.99 (d, *J* = 3.6 Hz, 1H), 3.39 (d, *J* = 16.8 Hz, 6H), 1.28 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.6, 138.3, 134.9, 130.2, 124.8, 119.9, 117.7, 101.8, 71.3, 48.9, 48.8, 17.0. HRMS (ESI), *m*/*z* calcd for C~12~H~16~ClNNaO~4~ (\[M + Na\]^+^), 296.0660; found, 296.0660.

### 4.2.14. *N*-(2-Chlorophenyl)-2-hydroxy-3,3-dimethoxybutanamide (**2n**) {#sec4-2-14}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (28 mg, 51%); ^1^H NMR (600 MHz, CDCl~3~): δ 9.44 (s, 1H), 8.37 (dd, *J* = 8.4, 1H), 7.39 (dd, *J* = 8.4, 1H), 7.30 (t, *J* = 7.5 Hz, 1H), 7.07 (t, *J* = 7.5 Hz, 1H), 4.34 (d, 1H), 4.06 (d, *J* = 3.6 Hz, 1H), 3.41 (d, *J* = 13.8 Hz, 6H), 1.29 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 170.0, 134.4, 129.2, 127.9, 125.0, 123.0, 121.5, 101.8, 71.3, 49.0, 48.8, 17.0. HRMS (ESI), *m*/*z* calcd for C~12~H~16~ClNNaO~4~ (\[M + Na\]^+^), 296.0660; found, 296.0654.

### 4.2.15. 2-Hydroxy-3,3-dimethoxy-*N*-(4-nitrophenyl)butanamide (**2o**) {#sec4-2-15}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow solid (40 mg, 70%); mp: 94--96 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.85 (s, 1H), 8.37 (t, *J* = 2.0 Hz, 1H), 8.01--7.93 (m, 2H), 7.52 (t, *J* = 8.2 Hz, 1H), 4.32 (d, *J* = 3.2 Hz, 1H), 3.91 (d, *J* = 3.2 Hz, 1H), 3.40 (d, *J* = 16.4 Hz, 6H), 1.31 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 170.0, 148.7, 138.2, 130.1, 125.4, 114.5, 101.8, 71.6, 49.0, 17.1. HRMS (ESI), *m*/*z* calcd for C~12~H~16~N~2~NaO~4~ (\[M + Na\]^+^), 307.0901; found, 307.0902.

### 4.2.16. *N*,*N*′-(1,4-Phenylene)bis(2-hydroxy-3,3-dimethoxybutanamide) (**2p**) {#sec4-2-16}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a light yellow solid (16 mg, 20%); mp: 165--167 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.57 (s, 2H), 7.51 (s, 4H), 4.27 (d, 2H), 4.03 (d, 2H), 3.39 (d, *J* = 13.2 Hz, 12H), 1.28 (s, 6H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.4, 133.8, 120.5, 101.8, 71.1, 48.9, 48.7, 17.0. HRMS (ESI), *m*/*z* calcd for C~18~H~28~N~2~NaO~8~ (\[M + Na\]^+^), 423.1738; found, 423.1753.

### 4.2.17. *N*-Benzyl-2-hydroxy-3,3-dimethoxybutanamide (**2q**) {#sec4-2-17}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (37 mg, 74%); ^1^H NMR (400 MHz, CDCl~3~): δ 7.35 (t, *J* = 7.0, 2H), 7.32--7.26 (m, 3H), 7.01 (s, 1H), 4.55 (dd, *J* = 14.8, 6.0 Hz, 1H), 4.45 (dd, *J* = 14.8, 5.6 Hz, 1H), 4.16 (d, *J* = 3.2 Hz, 1H), 4.07 (d, *J* = 3.6 Hz, 1H), 3.31 (s, 3H), 3.26 (s, 3H), 1.19 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 171.3, 137.9, 128.8, 127.7, 127.6, 101.6, 70.6, 48.7, 48.5, 43.9, 16.8. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1207.

### 4.2.18. 2-Hydroxy-3,3-dimethoxy-*N*-(4-methylbenzyl)butanamide (**2r**) {#sec4-2-18}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (36 mg, 67%); ^1^H NMR (600 MHz, CDCl~3~): δ 7.15 (s, 4H), 6.97 (s, 1H), 4.50 (dd, *J* = 14.7, 5.7 Hz, 1H), 4.40 (dd, *J* = 14.4, 4.8 Hz, 1H), 4.11 (d, *J* = 33.0 Hz, 2H), 3.30 (s, 3H), 3.25 (s, 3H), 2.34 (s, 3H), 1.18 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 171.2, 137.4, 134.8, 129.4, 127.6, 101.6, 70.6, 48.6, 48.5, 43.7, 21.1, 16.8. HRMS (ESI), *m*/*z* calcd for C~14~H~21~NNaO~4~ (\[M + Na\]^+^), 290.1363; found, 290.1362.

### 4.2.19. *N*-Cyclohexyl-2-hydroxy-3,3-dimethoxy-3-phenylpropanamide (**2s**) {#sec4-2-19}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (44 mg, 72%); mp: 137--139 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 7.42 (dd, *J* = 6.8, 2H), 7.33--7.30 (m, 3H), 6.44 (d, *J* = 7.6 Hz, 1H), 4.37 (d, *J* = 4.4 Hz, 1H), 3.74--3.69 (m, 1H), 3.67 (d, *J* = 4.4 Hz, 1H), 3.46 (s, 3H), 3.30 (s, 3H), 1.89--1.57 (m, 6H), 1.39--1.10 (m, 6H). ^13^C NMR (100 MHz, CDCl~3~): δ 168.8, 135.8, 128.5, 127.8, 127.7, 103.0, 71.6, 49.8, 49.2, 48.5, 33.0, 32.9, 25.5, 24.7. HRMS (ESI), *m*/*z* calcd for C~17~H~25~NNaO~4~ (\[M + Na\]^+^), 330.1676; found, 330.1676.

### 4.2.20. 2-Hydroxy-3,3-dimethoxy-*N*,*N*-dimethylbutanamide (**2t**) {#sec4-2-20}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white oil (21 mg, 54%); ^1^H NMR (400 MHz, CDCl~3~): δ 4.59 (d, *J* = 8.0 Hz, 1H), 3.91 (d, *J* = 8.4 Hz, 1H), 3.33 (s, 3H), 3.21 (s, 3H), 3.08 (s, 3H), 3.01 (s, 3H), 1.20 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 172.1, 102.9, 67.6, 48.5, 48.3, 37.8, 36.5, 17.2. HRMS (ESI), *m*/*z* calcd for C~8~H~17~NNaO~4~ (\[M + Na\]^+^), 214.1050; found, 214.1049.

### 4.2.21. 2-Hydroxy-3,3-dimethoxy-*N*,3-diphenylpropanamide (**2x**) {#sec4-2-21}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (18 mg, 30%); mp: 112--114 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.39 (s, 1H), 7.44--7.41 (m, 4H), 7.34 (t, *J* = 7.8 Hz, 2H), 7.31--7.27 (m, 3H), 7.14 (t, *J* = 7.4 Hz, 1H), 4.58 (d, *J* = 4.4 Hz, 1H), 3.62 (d, *J* = 4.8 Hz, 1H), 3.54 (s, 3H), 3.35 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 168.4, 137.1, 135.6, 129.1, 128.7, 128.0, 127.5, 124.7, 120.0, 103.3, 72.2, 50.0, 49.3. HRMS (ESI), *m*/*z* calcd for C~17~H~19~NNaO~4~ (\[M + Na\]^+^), 324.1206; found, 324.1214.

### 4.2.22. 2-Hydroxy-3,3-dimethoxy-*N*-phenylpentanamide (**2y**) {#sec4-2-22}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (25 mg, 50%); ^1^H NMR (600 MHz, CDCl~3~): δ 8.68 (s, 1H), 7.51 (d, *J* = 7.8 Hz, 2H), 7.35 (t, *J* = 7.8 Hz, 2H), 7.14 (t, *J* = 7.2 Hz, 1H), 4.27 (d, *J* = 3.6 Hz, 1H), 4.07 (d, *J* = 3.6 Hz, 1H), 3.38 (d, *J* = 16.2 Hz, 6H), 1.91 (dd, *J* = 15.0, 7.8 Hz, 1H), 1.77 (dd, *J* = 15.0, 7.2 Hz, 1H), 0.89 (t, *J* = 7.8 Hz, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 169.8, 137.2, 129.2, 124.7, 119.8, 103.3, 70.6, 49.2, 48.9, 24.6, 8.1. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1206.

### 4.2.23. 2-Hydroxy-3,3-dimethoxy-4-methyl-*N*-phenylpentanamide (**2z**) {#sec4-2-23}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a white solid (11 mg, 20%); mp: 51--53 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.67 (s, 1H), 7.51 (d, *J* = 7.8 Hz, 2H), 7.35 (t, *J* = 8.1 Hz, 2H), 7.14 (t, *J* = 7.5 Hz, 1H), 4.30 (d, *J* = 3.6 Hz, 1H), 3.98 (d, *J* = 3.6 Hz, 1H), 3.42 (s, 3H), 3.35 (s, 3H), 2.23--2.21 (m, 1H), 1.07 (d, *J* = 7.2 Hz, 3H), 0.98 (d, *J* = 7.2 Hz, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 170.3, 137.2, 129.2, 124.6, 119.8, 103.9, 71.0, 49.1, 49.1, 33.0, 17.7, 17.6. HRMS (ESI), *m*/*z* calcd for C~14~H~21~NNaO~4~ (\[M + Na\]^+^), 290.1363; found, 290.1354.

### 4.2.24. 2-Hydroxy-2-(2-methyl-1,3-dioxolan-2-yl)-*N*-phenylacetamide (**2b′**) {#sec4-2-24}

The product was isolated by flash chromatography (eluent: EA/PE = 1/10) as a white solid (9 mg, 20%); mp: 67--69 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.46 (s, 1H), 7.55 (d, *J* = 7.8 Hz, 2H), 7.35 (t, *J* = 7.5 Hz, 2H), 7.14 (t, *J* = 7.5 Hz, 1H), 4.12 (s, 1H), 4.09 (m, 4H), 3.89 (s, 1H), 1.43 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 168.1, 137.1, 129.1, 124.7, 119.9, 119.8, 109.4, 100.0, 73.8, 65.6, 65.0, 29.7, 19.7. HRMS (ESI), *m*/*z* calcd for C~12~H~15~NNaO~4~ (\[M + Na\]^+^), 260.0893; found, 260.0893.

### 4.2.25. 2-Hydroxy-3,3-dimethoxy-2-methyl-*N*-phenylbutanamide (**2d′**) {#sec4-2-25}

The product was isolated by flash chromatography (eluent: EA/PE = 1/15) as a yellow oil (21 mg, 41%); ^1^H NMR (600 MHz, CDCl~3~): δ 8.82 (s, 1H), 7.53 (d, *J* = 7.2 Hz, 2H), 7.34 (t, *J* = 7.2 Hz, 2H), 7.12 (t, *J* = 6.9 Hz, 1H), 4.28 (s, 1H), 3.43 (s, 3H), 3.39 (s, 3H), 1.54 (s, 3H), 1.47 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 172.5, 137.6, 129.0, 124.3, 119.8, 103.5, 79.3, 51.4, 51.2, 23.4, 15.7. HRMS (ESI), *m*/*z* calcd for C~13~H~19~NNaO~4~ (\[M + Na\]^+^), 276.1206; found, 276.1204.

4.3. Typical Experimental Procedure for **3** (**3a** as an Example) {#sec4-3}
--------------------------------------------------------------------

To a round-bottom flask (25 mL) was added 2-hydroxy-3,3-dimethoxy-*N*-phenyl-butanamide **2a** (47.8 mg, 0.2 mmol), and the mixture was well-stirred for 1 h in H~2~SO~4~ (1.0 mL) at 25 °C (the whole process was closely monitored by TLC). After the completion of the reaction, the residue was purified by a short flash silica gel column chromatography (eluent: EA/PE = 1/15) to give 3-hydroxy-4-methylquinolin-2(1*H*)-one **3a** as a white solid (23 mg, 66%).

### 4.3.1. 3-Hydroxy-4-methylquinolin-2(1*H*)-one (**3a**) {#sec4-3-1}

The product was isolated by flash chromatography (eluent: EA/PE = 1/10) as a white solid (23 mg, 66%); mp: 222--224 °C; ^1^H NMR (600 MHz, DMSO): δ 11.98 (s, 1H), 9.08 (s, 1H), 7.59 (d, *J* = 7.8 Hz, 1H), 7.30 (dd, *J* = 24.9, 7.5 Hz, 2H), 7.19 (t, *J* = 7.5 Hz, 1H), 2.28 (s, 3H). ^13^C NMR (150 MHz, DMSO): δ 158.3, 143.3, 133.4, 126.8, 123.7, 122.6, 121.8, 119.8, 115.6, 11.0. HRMS (ESI), *m*/*z* calcd for C~10~H~10~NO~2~ (\[M + H\]^+^), 176.0706; found, 176.0711.

### 4.3.2. 3-Hydroxy-4,6-dimethylquinolin-2(1*H*)-one (**3f**) {#sec4-3-2}

The product was isolated by flash chromatography (eluent: EA/PE = 1/10) as a white solid (28 mg, 75%); mp: 231--233 °C; ^1^H NMR (400 MHz, DMSO): δ 11.89 (s, 1H), 9.00 (s, 1H), 7.38 (s, 1H), 7.16 (q, *J* = 8.4 Hz, 2H), 2.36 (s, 3H), 2.26 (s, 3H). ^13^C NMR (100 MHz, DMSO): δ 157.6, 142.8, 130.9, 130.9, 127.4, 122.9, 121.2, 119.1, 115.0, 20.8, 10.5. HRMS (ESI), *m*/*z* calcd for C~11~H~12~NO~2~ (\[M + H\]^+^), 190.0863; found, 190.0867.

### 4.3.3. 3-Hydroxy-4,6,8-trimethylquinolin-2(1*H*)-one (**3i**) {#sec4-3-3}

The product was isolated by flash chromatography (eluent: EA/PE = 1/10) as a white solid (34 mg, 84%); mp: 237--239 °C; ^1^H NMR (600 MHz, DMSO): δ 11.06 (s, 1H), 9.04 (s, 1H), 7.25 (s, 1H), 7.01 (s, 1H), 2.39 (s, 3H), 2.32 (s, 3H), 2.26 (s, 3H). ^13^C NMR (150 MHz, DMSO): δ 158.5, 143.0, 131.1, 129.8, 129.7, 123.6, 121.8, 121.5, 120.0, 21.1, 17.9, 11.2. HRMS (ESI), *m*/*z* calcd for C~12~H~14~NO~2~ (\[M + H\]^+^), 204.1019; found, 204.1026.

### 4.3.4. 6-Chloro-3-hydroxy-4-methylquinolin-2(1*H*)-one (**3l**) {#sec4-3-4}

The product was isolated by flash chromatography (eluent: EA/PE = 1/10) as a white solid (21 mg, 55%); mp: 188--190 °C; ^1^H NMR (600 MHz, DMSO): δ 12.10 (s, 1H), 9.36 (s, 1H), 7.59 (s, 1H), 7.35 (d, *J* = 8.4 Hz, 1H), 7.27 (d, *J* = 9.0 Hz, 1H), 2.25 (s, 3H). ^13^C NMR (150 MHz, DMSO): δ 158.1, 144.2, 132.2, 126.8, 126.6, 123.4, 122.9, 119.1, 117.3, 10.9. HRMS (ESI), *m*/*z* calcd for C~10~H~9~ClNO~2~ (\[M + H\]^+^), 210.0316; found, 210.0316.

4.4. Typical Experimental Procedure for **4** (**4l** as an Example) {#sec4-4}
--------------------------------------------------------------------

To a round-bottom flask (25 mL) was added *N*-(4-chlorophenyl)-2-hydroxy-3,3-dimethoxybutanamide **2l** (35, 0.2 mmol), and the mixture was well-stirred for 1 h in H~2~SO~4~ (1.0 mL) at 25 °C (the whole process was closely monitored by TLC). After the completion of the reaction, the residue was purified by a short flash silica gel column chromatography (eluent: EA/PE = 1/20) to give *N*-(4-chlorophenyl)-2-hydroxy-3-oxobutanamide **4l** as a white solid (28 mg, 62%).

### 4.4.1. 2-Hydroxy-*N*-mesityl-3-oxobutanamide (**4j**) {#sec4-4-1}

The product was isolated by flash chromatography (eluent: EA/PE = 1/18) as a white solid (23 mg, 48%); mp: 70--72 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.02 (s, 1H), 6.89 (s, 2H), 4.85 (s, 1H), 4.57 (s, 1H), 2.54 (s, 3H), 2.26 (s, 3H), 2.13 (s, 6H). ^13^C NMR (150 MHz, CDCl~3~): δ 204.9, 165.2, 137.4, 134.8, 129.8, 129.1, 79.2, 26.1, 20.9, 18.1. HRMS (ESI), *m*/*z* calcd for C~13~H~17~NNaO~3~ (\[M + Na\]^+^), 258.1101; found, 258.1101.

### 4.4.2. *N*-(4-Chlorophenyl)-2-hydroxy-3-oxobutanamide (**4l**) {#sec4-4-2}

The product was isolated by flash chromatography (eluent: EA/PE = 1/18) as a yellow solid (28 mg, 62%); mp: 74--76 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.58 (s, 1H), 7.50 (d, *J* = 8.4 Hz, 2H), 7.31 (d, *J* = 7.8 Hz, 2H), 4.77 (s, 1H), 4.59 (s, 1H), 2.56 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 203.9, 164.5, 135.2, 130.1, 129.2, 121.1, 78.9, 26.2. HRMS (ESI), *m*/*z* calcd for C~10~H~11~ClNO~3~ (\[M + H\]^+^), 228.0422; found, 228.0423.

### 4.4.3. 2-Hydroxy-*N*-(4-nitrophenyl)-3-oxobutanamide (**4o**) {#sec4-4-3}

The product was isolated by flash chromatography (eluent: EA/PE = 1/18) as a yellow oil (24 mg, 50%); ^1^H NMR (600 MHz, CDCl~3~): δ 8.83 (s, 1H), 8.51 (s, 1H), 8.01 (d, *J* = 7.8 Hz, 1H), 7.87 (d, *J* = 7.8 Hz, 1H), 7.52 (t, *J* = 8.1 Hz, 1H), 4.82 (s, 1H), 4.63 (s, 1H), 2.58 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 203.4, 165.0, 148.7, 137.8, 130.0, 125.3, 119.6, 114.7, 78.9, 26.2. HRMS (ESI), *m*/*z* calcd for C~10~H~10~N~2~NaO~5~ (\[M + Na\]^+^), 261.0482; found, 261.0483.

### 4.4.4. *N*-Cyclohexyl-2-hydroxy-3-oxo-3-phenylpropanamide (**4s**) {#sec4-4-4}

The product was isolated by flash chromatography (eluent: EA/PE = 1/18) as a white solid (46 mg, 88%); mp: 90--92 °C; ^1^H NMR (600 MHz, CDCl~3~): δ 8.22 (d, *J* = 7.8 Hz, 2H), 7.62 (t, *J* = 7.2 Hz, 1H), 7.50 (t, *J* = 7.5 Hz, 2H), 6.78 (s, 1H), 5.50 (s, 1H), 3.65 (d, *J* = 9.6 Hz, 1H), 1.93 (d, *J* = 11.4 Hz, 1H), 1.75--1.57 (m, 5H), 1.33--1.10 (m, 6H). ^13^C NMR (150 MHz, CDCl~3~): δ 196.3, 165.9, 134.7, 133.2, 130.9, 128.3, 75.5, 48.4, 32.8, 32.8, 25.4, 24.8. HRMS (ESI), *m*/*z* calcd for C~15~H~20~NO~3~ (\[M + H\]^+^), 262.1438; found, 262.1438.

### 4.4.5. 2-Hydroxy-*N*,*N*-dimethyl-3-oxobutanamide (**4t**) {#sec4-4-5}

The product was isolated by flash chromatography (eluent: EA/PE = 1/18) as a white oil (17 mg, 60%); ^1^H NMR (600 MHz, CDCl~3~): δ 4.79 (d, *J* = 7.2 Hz, 1H), 4.59 (d, *J* = 6.6 Hz, 1H), 3.09 (s, 3H), 3.03 (s, 3H), 2.21 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 206.5, 167.7, 76.1, 37.1, 36.5, 25.4. HRMS (ESI), *m*/*z* calcd for C~6~H~12~NO~3~ (\[M + H\]^+^), 146.0812; found, 146.0813.
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